Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BioDiscovery Releases Nexus Copy Number Version 7

Published: Thursday, April 18, 2013
Last Updated: Thursday, April 18, 2013
Bookmark and Share
Version 7 offers DNA copy number and sequence variation analysis and visualization.

BioDiscovery, Inc. has announced the release of version 7 of Nexus Copy Number software, the leading platform independent and user friendly application for analysis of structural variation from CGH array, SNP array and NGS platforms.

Version 7 offers numerous new capabilities including support for small sequence variations, such as point mutations, InDels, inversions, etc. as well as new computational and visualization tools for identifying and displaying significant co-occurring aberrations, and processing samples using ASCAT2.

Nexus Copy Number is platform independent and can load virtually any data using its predefined data types or user-created custom data types.

BioDiscovery Nexus Copy Number has enabled users to efficiently detect, visualize, and interpret copy number and allelic event changes across many application areas for several years.

With Nexus Copy Number version 7, sequence variations can now be interpreted alongside copy number changes for an integrated view of genomic aberrations.

This unique feature of integrated analysis allows identification of mutations overlapping copy number aberrations or homozygous regions in addition to identification of novel disease causing mutations.

A new concordance tool allows identification of co-occurring aberrations and many new filtering schemas facilitate quickly narrowing down list of genes implicated in specific types of aberrations.

“With sequencing costs decreasing and widespread use of NGS technologies, researchers have much more sequence variation data at hand and need a way to make sense out of them,” said Dr. Soheil Shams, CEO, BioDiscovery, Inc.

Dr. Shams continued, “Nexus Copy Number offers a unique composition of analysis and visualization of sequence variations, copy number changes, and allelic event changes together, allowing researchers to advance their findings with a broad picture of the genomic landscape.”

BioDiscovery Nexus Copy Number can integrate and process together, in a single project, data from commercial array platforms such as Agilent, Affymetrix, Illumina, Roche NimbleGen, Next-Gen read depth and small sequence variations, as well as custom arrays.

With its free access to a web-based repository for querying and storing genomic data from any location across the globe, BioDiscovery Nexus Copy Number is a powerful solution for large groups such as special consortia.

The software is applicable to many types of studies from focused projects of a cytogeneticist to large scale cancer or GWAS studies.

BioDiscovery is attuned to such different needs and offers the product in a flexible and modular system allowing users to create configurations that are suited to their needs.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

BioDiscovery Awarded National Institutes of Health SBIR Grant
SBIR Phase I grant to improve the copy number variation data from TCGA.
Thursday, July 10, 2014
N-of-One and BioDiscovery Partner
Partnership equips laboratories and oncologists with a foundation for genomic data analysis through to therapeutic options.
Tuesday, March 25, 2014
BioDiscovery Initiates Software Donation Program to Benefit Pediatric Research
Company to donate up to $100,000 worth of software licenses per year to eligible scientists working in pediatric research.
Monday, January 07, 2013
BioDiscovery and AGRE Enter into a Co-Promotion Agreement
Agreement allows AGRE to provide copy number and allelic event data to its research users.
Wednesday, September 19, 2012
Fox Chase Cancer Center Adopts Nexus Copy Number and Nexus Expression
The center's Keystone Program in Blood Cell Development and Cancer gains a site license for two bioinformatics software programs from BioDiscovery.
Wednesday, February 11, 2009
Scientific News
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
Higher Frequency of Huntington's Disease Mutations Discovered
University of Aberdeen study shows that the gene change that causes Huntington's disease is much more common than previously thought.
Revealing the Genetic Causes of Bowel Cancer
A landmark study has given the most detailed picture yet of the genetics of bowel cancer — the UK's fourth most common cancer.
The Epigenetic Influences of Chronic Pain
Researchers at Drexel University College of Medicine are aiming to identify new molecular mechanisms involved in pain.
Fighting Resistant Blood Cancer Cells
Biologists present new findings on chronic myeloid leukemia and possible therapeutic approaches.
Tumor Cells Develop Predictable Characteristics
Scientists have discovered that cancer cells at the edge of a tumor that are close to the surrounding environment are predictably different from the cells within the interior of the tumor.
Mothers Obesity Could be Passed on in mtDNA
Obesity can predispose offspring in multiple generations to metabolic problems.
New Imaging Method Reveals Nanoscale Details about DNA
Enhancement to super-resolution microscopy shows orientation of individual molecules, providing a new window into DNA’s structure and dynamics.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
Naked Mole Rat Exhibits “Extraordinary” Cancer Resistance
Scientists are getting closer to understanding the anti-cancer mechanism of the naked mole rat by making induced pluripotent stem cells.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!